Marandino, L. Et Al. 2023. The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.. Minerva urology and nephrology , vol.75, no.2 , 260-264.

Marandino, L., Ciccarese, C., Francolini, G., Amparore, D., Campi, R., Bertolo, R., ... Borregales, L. D.(2023). The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.. Minerva urology and nephrology , vol.75, no.2, 260-264.

Marandino, Laura Et Al. "The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.," Minerva urology and nephrology , vol.75, no.2, 260-264, 2023

Marandino, Laura Et Al. "The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.." Minerva urology and nephrology , vol.75, no.2, pp.260-264, 2023

Marandino, L. Et Al. (2023) . "The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.." Minerva urology and nephrology , vol.75, no.2, pp.260-264.

@article{article, author={Laura Marandino Et Al. }, title={The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.}, journal={Minerva urology and nephrology}, year=2023, pages={260-264} }